Med. praxi. 2019;16(1):48-52 | DOI: 10.36290/med.2019.007

Prostate cancer – what should we know about diagnostics

MUDr. Milan Král, Ph.D., MUDr. Šárka Kudláčková

Urologická klinika LF UP a FN Olomouc

During the last few decades we can see increasing incidence of prostate cancer. This is caused partially due to increased activity of medical stuff and partially due to higher information level of patients about potential risk of harbouring prostate cancer. Contrary to other oncological diagnosis (breast cancer, colorectal cancer), in prostate cancer the reason for screening programmes is widely discussed. Many multicentric projects assessed screening influence on prostate cancer mortality reduction. Conclusions both European and U.S. studies uniformly show that despite increased detection of prostate cancer, neither the cancer specific mortality nor overall survival improved. Based on these conclusions it is not recommended to perform wide but so called oportunistic screening. It means to examine men in risk age with regard to race and positive family history for prostate cancer with life expectancy at least 10–15 years. Aim of screening programmes is to increase detection of intermediate and high risk prostate cancers because especially these men profit the most from early detection and starting of active treatment, i.e. radical prostatectomy or radiotherapy.

Keywords: prostate cancer, diagnostics, screening

Published: February 25, 2019  Show citation